NCEL Stock Latest News

NewcelX initiated with a Buy at Laidlaw

PremiumThe Fly

4d ago

NewcelX Strengthens Diabetes Push With Appointment of Leading Transplant Pioneer Camillo Ricordi

PremiumCompany Announcements

8d ago

NewcelX Wins FDA Backing to Advance NCEL-101 Toward Type 1 Diabetes Trials

PremiumCompany Announcements

15d ago

NewcelX completes Type B Pre-IND meeting with FDA for NCEL-101

PremiumThe Fly

15d ago

PremiumCompany AnnouncementsNewcelX Shareholders Approve All Proposals at June 30 Annual Meeting

16d ago

NewcelX Stem Cell Platform Strengthened by Peer-Reviewed AstroRx Study in Multiple Sclerosis

Company Announcements

NewcelX Stem Cell Platform Strengthened by Peer-Reviewed AstroRx Study in Multiple Sclerosis

1M ago

NewcelX Calls June 30, 2026 Shareholders’ Meeting as 2025 Losses Deepen

Company Announcements

NewcelX Calls June 30, 2026 Shareholders’ Meeting as 2025 Losses Deepen

1M ago

NewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA

PremiumThe Fly

2M ago

NewcelX Files Pre-IND With FDA for NCEL-101 Type 1 Diabetes Cell Therapy

PremiumCompany Announcements

2M ago

NewcelX files to sell 2.26M common shares for holders

PremiumThe Fly

2M ago

NewcelX Posts 2025 Results and Bolsters Funding to Accelerate Type 1 Diabetes Program

PremiumCompany Announcements

3M ago

PremiumCompany AnnouncementsNewcelX Highlights Type 1 Diabetes Flagship and Eledon Collaboration in Updated April 2026 Presentation

3M ago

NewcelX announces release of updated presentation on Type 1 Diabetes program

The Fly

NewcelX announces release of updated presentation on Type 1 Diabetes program

3M ago

Company Announcements

NewcelX Raises $1.35 Million in Premium-Priced Private Placement to Advance Type 1 Diabetes Program

4M ago

NewcelX Forms Eledon Alliance to Accelerate NCEL-101 Diabetes Program

PremiumCompany Announcements

4M ago

NewcelX announces research agreement with Eledon Pharmaceuticals

PremiumThe Fly

4M ago

NewcelX Cites Peer-Reviewed Mazindol Data as It Advances CVR-Linked Asset Talks

PremiumCompany Announcements

5M ago

NewcelX Updates Corporate Presentation as It Sharpens Focus on Type 1 Diabetes Cell Therapies

PremiumCompany Announcements

6M ago

NewcelX Reports Positive International Study Results on Biomaterial-Based Islet Delivery for Type 1 Diabetes

PremiumCompany AnnouncementsNewcelX Reports Positive International Study Results on Biomaterial-Based Islet Delivery for Type 1 Diabetes

6M ago

NewcelX Adds Swiss Diabetes Leader to Advisory Board to Steer IsletRx Program

Company Announcements

NewcelX Adds Swiss Diabetes Leader to Advisory Board to Steer IsletRx Program

6M ago

NewcelX Strengthens IP Portfolio with Chinese Patent Publication

Company Announcements

NewcelX Strengthens IP Portfolio with Chinese Patent Publication

7M ago